Skip to content

What are the ingredients in Tiadylt? A Guide to Its Components

3 min read

Diltiazem hydrochloride is the primary therapeutic component of Tiadylt ER, a medication used to treat hypertension and angina. This guide details what are the ingredients in Tiadylt, exploring both the active and inactive compounds that enable its extended-release properties.

Quick Summary

Tiadylt is an extended-release capsule with the active ingredient diltiazem hydrochloride, a calcium channel blocker used for heart conditions, along with various inactive fillers and capsule components.

Key Points

  • Active Ingredient: Diltiazem hydrochloride is the single active component responsible for Tiadylt's therapeutic effects as a calcium channel blocker.

  • Extended-Release Pellets: The medication is delivered via a capsule filled with small pellets, not a solid tablet, designed for controlled release over a 24-hour period.

  • Complex Inactive Ingredients: Excipients like ethyl cellulose, hypromellose, and colloidal silicon dioxide are crucial for the specialized function of the extended-release mechanism.

  • Dosage-Specific Colors: The capsule shells contain different dyes (FD&C blue and red) depending on the dose, which helps with visual identification.

  • Do Not Crush: The capsule's controlled-release technology is destroyed by crushing or chewing, which can lead to a dangerous overdose of the medication.

  • Sprinkling is an Option: For patients with swallowing difficulties, the capsule contents can be safely sprinkled onto a spoonful of applesauce.

  • Drug-Drug Interactions: Because diltiazem is metabolized by the CYP3A4 enzyme system, there are significant potential drug interactions with other medications.

In This Article

The Active Ingredient: Diltiazem Hydrochloride

At the core of Tiadylt's therapeutic action is its single active ingredient, diltiazem hydrochloride. This compound belongs to a class of medications known as non-dihydropyridine calcium channel blockers. Its primary function involves inhibiting calcium influx during depolarization of cardiac and vascular smooth muscle, helping to relax blood vessels and lower blood pressure. For patients with high blood pressure (hypertension) or chest pain (angina), this helps the heart work less strenuously.

The Role of Inactive Ingredients

Inactive ingredients are essential components of any medication, serving several important functions beyond the therapeutic effect of the active compound. In Tiadylt, these ingredients facilitate the drug's extended-release profile, ensure its stability, and provide the physical characteristics of the capsule. The formulation is designed to release diltiazem slowly over a 24-hour period, which requires a specific combination of excipients to achieve.

The Capsule Pellets and Excipients

Tiadylt is an extended-release capsule containing white to off-white pellets. The inactive ingredients in these pellets, which help control drug release, include colloidal silicon dioxide, ethyl cellulose, gelatin, hypromellose (hydroxypropyl methylcellulose), polyethylene glycol, sugar spheres, talc, and titanium dioxide. These components act as glidants, sustained-release agents, binders, plasticizers, and core materials.

The Capsule Shell and Printing Ink

The capsule shell and ink also contain various components. The coloring of the capsule shell can vary depending on the dosage strength, using dyes such as FD&C blue #1 and various FD&C red dyes. The pharmaceutical ink contains several components, including black iron oxide and shellac.

Comparison Table: Tiadylt ER vs. Common Diltiazem Variants

Tiadylt is one of several branded and generic forms of diltiazem extended-release capsules. Key differences often exist in their inactive ingredients, which can affect their administration and release characteristics {Link: Dailymed https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1278cd76-b8e9-42d9-ad19-6858e72cf9f2}.

Feature Tiadylt ER Cardizem CD / Tiazac General Immediate-Release Diltiazem
Formulation Extended-Release Capsules Extended-Release Capsules Immediate-Release Tablets
Release Profile Once daily, controlled release Once daily, controlled release Multiple times per day, rapid release
Sprinkle on Food Contents can be sprinkled on applesauce. Can be opened and sprinkled on food. Cannot be altered; swallowed whole.
Crushing or Chewing Do not crush or chew; destroys the extended-release mechanism. Do not crush or chew; destroys the extended-release mechanism. Do not crush or chew unless specifically advised; can alter release.
Example Excipients Ethyl cellulose, sugar sphere, talc. Varies by manufacturer; often uses similar polymers for extended-release. Typically uses standard binders and fillers like lactose and magnesium stearate.

Proper Administration for Controlled Release

Proper administration of Tiadylt is critical for safety and effectiveness. The coated pellets are designed for a slow, steady release over 24 hours. Crushing or chewing the capsule defeats this mechanism, leading to a rapid release of the entire dose, which can cause dangerously low blood pressure or heart rhythm problems. For those with swallowing difficulties, the capsule can be opened and the contents sprinkled on a spoonful of cool applesauce and swallowed immediately without chewing.

Conclusion

Understanding the ingredients in Tiadylt highlights how both the active diltiazem hydrochloride and the various inactive ingredients work together to provide a once-daily, extended-release treatment for hypertension and angina. The inactive components are crucial for the controlled release mechanism and the drug's stability. Proper administration, such as avoiding crushing or chewing, is essential for the medication to work correctly and safely. Always consult a healthcare professional for questions about medication components or use.

Frequently Asked Questions

The active ingredient in Tiadylt is diltiazem hydrochloride. It functions as a calcium channel blocker to relax blood vessels and control heart rate.

Tiadylt is an extended-release medication that contains small, coated pellets inside a capsule. This design is necessary to ensure the drug is released slowly and consistently over a 24-hour period for once-daily dosing.

No, you should never crush or chew Tiadylt extended-release capsules. Altering the capsule will destroy the controlled-release mechanism, causing the entire dose to be released at once, which can lead to severe side effects.

Inactive ingredients in Tiadylt include colloidal silicon dioxide, ethyl cellulose, hypromellose, polyethylene glycol, sugar spheres, talc, and titanium dioxide {Link: Dailymed https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1278cd76-b8e9-42d9-ad19-6858e72cf9f2}.

Yes, for patients who have difficulty swallowing, the Tiadylt capsule can be opened and the contents sprinkled on a spoonful of applesauce. The mixture must be swallowed immediately without chewing {Link: Dailymed https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1278cd76-b8e9-42d9-ad19-6858e72cf9f2}.

Yes, the color of the Tiadylt capsule shell varies depending on the dosage strength. This helps patients and healthcare providers visually differentiate between different doses.

The inactive ingredients in Tiadylt serve several functions, including binding the pellet components, providing the controlled-release coating, and ensuring the physical stability and consistency of the drug.

Tiadylt is manufactured by Zydus Lifesciences Ltd., with distribution handled by Zydus Pharmaceuticals USA Inc..

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.